4.6 Article

Human Cytomegalovirus Early Protein pUL21a Promotes Efficient Viral DNA Synthesis and the Late Accumulation of Immediate-Early Transcripts

Journal

JOURNAL OF VIROLOGY
Volume 85, Issue 2, Pages 663-674

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01599-10

Keywords

-

Categories

Funding

  1. Public Health Service grant [R01 CA120768]
  2. American Heart Association [09GRNT2290199]
  3. Children's Discovery Institute at Washington University
  4. Burroughs Wellcome Fund
  5. Institutional Training Grant [T32-AI007172]
  6. NATIONAL CANCER INSTITUTE [R01CA120768] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We have previously reported that a newly annotated gene of human cytomegalovirus (HCMV), UL21a, encodes an early viral protein termed pUL21a. Most notably, the virions of a UL21a deletion virus had markedly reduced infectivity, indicating that UL21a is required to establish an efficient productive infection. In this study, we infected fibroblasts with equal numbers of DNA-containing viral particles and identified where in the viral life cycle pUL21a acted. The UL21a deletion virus entered cells and initiated viral gene expression efficiently; however, it synthesized viral DNA poorly and accumulated several immediate-early (IE) transcripts at reduced levels at late times of infection. The defect in viral DNA synthesis preceded that in gene expression, and inhibition of viral DNA synthesis reduced the late accumulation of IE transcripts in both wild-type and mutant virus-infected cells to equivalent levels. This suggests that reduced viral DNA synthesis is the cause of reduced IE gene expression in the absence of UL21a. The growth of UL21a deletion virus was similar to that of recombinant HCMV in which pUL21a expression was abrogated by stop codon mutations, and the defect was rescued in pUL21a-expressing fibroblasts. pUL21a expression in trans was sufficient to restore viral DNA synthesis and gene expression of mutant virus produced from normal fibroblasts, whereas mutant virus produced from complementing cells still exhibited the defect in normal fibroblasts. Thus, pUL21a does not promote the functionality of HCMV virions; rather, its de novo synthesis facilitates viral DNA synthesis, which is necessary for the late accumulation of IE transcripts and establishment of a productive infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Virology

The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation

Yousef M. O. Alhammad, Anthony R. Fehr

VIRUSES-BASEL (2020)

Article Biochemistry & Molecular Biology

Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity

Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, Yousef M. O. Alhammad, Mark S. Schmidt, Samuel A. J. Trammell, Stanley Perlman, Michael S. Cohen, Anthony R. Fehr, Charles Brenner

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Virology

Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication

Lynden S. Voth, Joseph J. O'Connor, Catherine M. Kerr, Ethan Doerger, Nancy Schwarting, Parker Sperstad, David K. Johnson, Anthony R. Fehr

Summary: The macrodomain Mac1 within nonstructural protein 3 of coronaviruses has been identified as essential for viral replication, with targeted mutations revealing multiple functions that contribute to the replication of the model CoV MHV. These findings suggest that Mac1 may be a potential target for anti-CoV therapeutics.

JOURNAL OF VIROLOGY (2021)

Article Biochemistry & Molecular Biology

ADP-ribosyltransferases, an update on function and nomenclature

Bernhard Luscher, Ivan Ahel, Matthias Altmeyer, Alan Ashworth, Peter Bai, Paul Chang, Michael Cohen, Daniela Corda, Francoise Dantzer, Matthew D. Daugherty, Ted M. Dawson, Valina L. Dawson, Sebastian Deindl, Anthony R. Fehr, Karla L. H. Feijs, Dmitri V. Filippov, Jean-Philippe Gagne, Giovanna Grimaldi, Sebastian Guettler, Nicolas C. Hoch, Michael O. Hottiger, Patricia Korn, W. Lee Kraus, Andreas Ladurner, Lari Lehtio, Anthony K. L. Leung, Christopher J. Lord, Aswin Mangerich, Ivan Matic, Jason Matthews, George-Lucian Moldovan, Joel Moss, Gioacchino Natoli, Michael L. Nielsen, Mario Niepel, Friedrich Nolte, John Pascal, Bryce M. Paschal, Krzysztof Pawlowski, Guy G. Poirier, Susan Smith, Gyula Timinszky, Zhao-Qi Wang, Jose Yelamos, Xiaochun Yu, Roko Zaja, Mathias Ziegler

Summary: ADP-ribosylation, a post-translational modification of proteins, nucleic acids, and metabolites, plays diverse roles in cellular processes such as stress responses, signaling, and transcriptional regulation. Recent advances in research have identified a wide range of cellular pathways regulated by ADP-ribosylation, highlighting the importance of understanding this mechanism in cell biology.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain

Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, Ajit Thomas, Robert Lyle McPherson, Aravinth Kumar Jayabalan, Veronica F. Busa, Shang-Jung Cheng, Brennan A. Murphy, Karli R. Redinger, Yousef M. O. Alhammad, Anthony R. Fehr, Takashi Tsukamoto, Barbara S. Slusher, Jurgen Bosch, Huijun Wei, Anthony K. L. Leung

Summary: Viral macrodomains are crucial for virus replication and pathogenesis, making them a promising target for antiviral therapy. Dasatinib has been identified as a potential ADP-ribosylhydrolase inhibitor, showing effectiveness against SARS-CoV-2 and MERS-CoV, but not affecting the closest human homologue MacroD2. This study demonstrates the feasibility of identifying selective inhibitors based on ADP-ribosylhydrolase activity and provides a potential avenue for developing better macrodomain inhibitors as antiviral therapies for SARS-CoV-2 and other viral threats.

ACS CHEMICAL BIOLOGY (2022)

Article Microbiology

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses

Anthony K. L. Leung, Diane E. Griffin, Juergen Bosch, Anthony R. Fehr

Summary: Emerging and re-emerging viral diseases pose continuous threats to public health. Developing a diverse portfolio of antiviral agents is crucial for effective control. The macrodomain, a drug target critical for the replication and pathogenesis of alphaviruses and coronaviruses, has the potential to block virus replication and restore the host's protective interferon response. Macrodomain inhibitors, with their well-defined binding pocket, offer an attractive target for developing direct acting antivirals and complementing current approaches in combating COVID-19 and future viral threats.

PATHOGENS (2022)

Article Multidisciplinary Sciences

MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells

Courtney E. Comar, Clayton J. Otter, Jessica Pfannenstiel, Ethan Doerger, David M. Renner, Li Hui Tan, Stanley Perlman, Noam A. Cohen, Anthony R. Fehr, Susan R. Weiss

Summary: MERS-CoV optimizes its replication by suppressing early innate immune pathways, including interferon production and signaling, through the actions of endoribonuclease (EndoU) and accessory proteins NS4a and NS4b.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Pharmacology & Pharmacy

Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

Anu Roy, Yousef M. Alhammad, Peter McDonald, David K. Johnson, Junlin Zhuo, Sarah Wazir, Dana Ferraris, Lari Lehtio, Anthony K. L. Leung, Anthony R. Fehr

Summary: This study focuses on screening for potential inhibitors of the SARS-CoV-2 conserved macrodomain (Mac1). Five compounds from three chemotypes were identified, which show inhibitory effects on Mac1-ADP-ribose binding, ADP-ribosylhydrolase activity, and direct Mac1 binding, making them strong candidates for the development of highly effective Mac1 inhibitors.

ANTIVIRAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain

Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, Anuradha Roy, Yousef M. Alhammad, Moriama Atobatele, Sarah Wazir, George Abbas, Patrick Keane, Junlin Zhuo, Anthony K. L. Leung, David K. Johnson, Lari Lehtio, Anthony R. Fehr, Dana Ferraris

Summary: A series of amino acid based compounds were designed and synthesized to investigate their inhibitory activity against the SARS-CoV-2 nsp3 macrodomain. Compound 15c was identified as a low-micromolar inhibitor and demonstrated selectivity for coronavirus macrodomains.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Microbiology

PARP14: A key ADP-ribosylating protein in host-virus interactions?

Srivatsan Parthasarathy, Anthony R. Fehr

Summary: The translation discusses the impact of posttranslational modifications (PTMs) on protein functions, focusing on the role of ADP-ribosylation. Specifically, it highlights the importance of PARP14, a MARylating enzyme, in anti-inflammatory and antiviral responses, while also emphasizing the need for further studies to elucidate its specific roles and mechanisms during viral infections.

PLOS PATHOGENS (2022)

Article Microbiology

Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles

Cindy Y. Ly, Jessica Pfannenstiel, Anil Pant, Zhilong Yang, Anthony R. Fehr, Maxim S. Rodzkin, David J. Davido

Summary: In this study, aurora kinase inhibitors were found to significantly reduce gene expression and viral replication of herpes simplex virus 1 (HSV-1). Furthermore, these inhibitors also showed inhibitory effects on the replication of other RNA and DNA viruses. These findings suggest a novel role for aurora kinases in the replication of diverse viruses.

MICROBIOLOGY SPECTRUM (2023)

Article Virology

PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner

Catherine M. Kerr, Srivatsan Parthasarathy, Nancy Schwarting, Joseph J. O'Connor, Jessica J. Pfannenstiel, Emily Giri, Sunil More, Robin C. Orozco, Anthony R. Fehr

Summary: PARP12 is an important mediator of the antiviral response to coronaviruses, but additional PARPs or innate immune factors contribute to virus attenuation in mice. PARP12 knockout increases Mac1 mutant virus replication and liver pathology in mice.

JOURNAL OF VIROLOGY (2023)

Article Microbiology

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses

Joseph J. O'Connor, Lynden Voth, Jeremiah Athmer, Nicholas M. George, Christopher M. Connelly, Anthony R. Fehr

Summary: Testing two commercially available blood collection tube blood-stabilization reagents, cfDNA and CytoChex, it was found that they can rapidly inactivate coronaviruses and effectively preserve viral RNA stability for a certain period of time.

PATHOGENS (2023)

Review Microbiology

An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors

Joseph J. O'Connor, Dana Ferraris, Anthony R. Fehr

Summary: This article summarizes the progress in the search for inhibitors of the SARS-CoV-2 Mac1 protein. Various unique chemical inhibitors have been successfully created using high-throughput screening and chemical modifications.

PATHOGENS (2023)

Article Virology

The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase

Yousef M. O. Alhammad, Maithri M. Kashipathy, Anuradha Roy, Jean-Philippe Gagne, Peter McDonald, Philip Gao, Louis Nonfoux, Kevin P. Battaile, David K. Johnson, Erik D. Holmstrom, Guy G. Poirier, Scott Lovell, Anthony R. Fehr

Summary: The Mac1 proteins in SARS-CoV-2 and other CoVs are MAR-hydrolases with similar functions, suggesting compounds targeting these proteins may have broad anti-CoV activity. Understanding the biochemistry and enzyme activity of these proteins is critical for developing novel therapeutic strategies against COVID-19.

JOURNAL OF VIROLOGY (2021)

No Data Available